Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. 
Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. 
For more information, please visit our website at www.miltenyibiomedicine.com.

Biotechnology

Clinical Trials

Medical Devices

Pharmaceutical

Miltenyi Biomedicine

Toon Overstijns

Michael Terhoeven

Dr. Sandra Karitzky

Peter Toth

Hans-Juergen Fuelle

Tomasz Skrzypczak

Hans - Jürgen Fülle

Andreas Woitossek

Anna Wijatyk

Clinical Research and Development

Regulatory Affairs and Market Access

Leadership Team

��

Teams at Miltenyi Biomedicine

Clinical Research and Development

Regulatory Affairs and Market Access

Leadership Team

��������

Teams at Miltenyi Biomedicine

Clinical Research and Development

Regulatory Affairs and Market Access

Leadership Team

��